A share price of Rockwell Medical Inc [RMTI] is currently trading at $1.65, up 17.02%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RMTI shares have gain 13.01% over the last week, with a monthly amount glided 23.13%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 8, February 2024, Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024. In a post published today on Yahoo Finance, Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the fourth quarter and full-year ended December 31, 2023 on Thursday, March 21, 2024. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.
From an analyst’s perspective:
Rockwell Medical Inc [NASDAQ: RMTI] stock has seen the most recent analyst activity on June 24, 2019, when Piper Jaffray initiated its Overweight rating and assigned the stock a price target of $10. Previously, H.C. Wainwright started tracking the stock with Buy rating on May 13, 2019, and set its price target to $11. On November 08, 2016, downgrade downgraded it’s rating to Underperform. Stifel downgraded its rating to a Hold. Morgan Stanley initiated its recommendation with a Underweight and recommended $7 as its price target on August 13, 2015. Oppenheimer reiterated a Outperform rating for this stock on January 27, 2015, and upped its price target to $26. In a note dated January 07, 2015, Oppenheimer initiated an Outperform rating and provided a target price of $24 on this stock.
Rockwell Medical Inc experienced fluctuations in its stock price throughout the past year between $1.16 and $6.24. Currently, Wall Street analysts expect the stock to reach $11 within the next 12 months. Rockwell Medical Inc [NASDAQ: RMTI] shares were valued at $1.65 at the most recent close of the market. An investor can expect a potential return of 566.67% based on the average RMTI price forecast.
Analyzing the RMTI fundamentals
Trailing Twelve Months sales for Rockwell Medical Inc [NASDAQ:RMTI] were 80.83M which represents 27.18% growth. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at -0.1%, Pretax Profit Margin comes in at -0.11%, and Net Profit Margin reading is -0.13%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.72 and Total Capital is -0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4867 points at the first support level, and at 1.3233 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7567, and for the 2nd resistance point, it is at 1.8633.
Rockwell Medical Inc [RMTI] reported earnings per share of -$0.07 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.1/share, meaning a difference of $0.03 and a surprise factor of 30.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.18 per share as compared to estimates of -$0.12 per share, a difference of -$0.06 representing a surprise of -50.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Rockwell Medical Inc [NASDAQ:RMTI] is 1.32. In addition, the Quick Ratio stands at 1.06 and the Cash Ratio stands at 0.36. Considering the valuation of this stock, the price to sales ratio is 0.58, the price to book ratio is 2.18.
